Alnylam PharmaceuticalsALNY
那斯達克 · USD
412.63
+8.17
(+2.02%)
收盤 12/12 04:59 (UTC+8)
12/12 04:59 (UTC+8)
Alnylam PharmaceuticalsALNY
412.63
+8.17
(+2.02%)
財務數據
損益表
- 3.19
- 7.51
- 4.40
- 4.94
- 6.60
- 5.01
- 5.93
- 5.94
- 7.74
- 12.49
- -0.17
- 135.46
- -41.41
- 12.42
- 33.48
- -24.08
- 18.42
- 0.17
- 30.21
- 61.44
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 1,249,026 | 773,689 | 594,189 | 593,166 | 500,919 | 659,825 | 494,333 | 439,718 | 750,530 | 318,754 |
營業成本 | 200,154 | 142,953 | 71,041 | 102,817 | 85,905 | 68,672 | 65,976 | 85,858 | 84,309 | 85,370 |
營業毛利 | 1,048,872 | 630,736 | 523,148 | 490,349 | 415,014 | 591,153 | 428,357 | 353,860 | 666,221 | 233,384 |
營業費用 | 680,890 | 646,935 | - | 595,508 | 491,919 | 542,539 | 471,792 | 470,264 | 452,354 | 463,215 |
研發費用 | 358,814 | 323,621 | 265,122 | 300,169 | 270,926 | 294,142 | 260,995 | 272,141 | 253,179 | 248,526 |
推銷及管理費用 | 322,076 | 323,314 | 239,949 | 295,339 | 220,993 | 248,397 | 210,797 | 198,123 | 199,175 | 214,689 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 367,982 | -16,199 | 18,077 | -105,159 | -76,905 | 48,614 | -43,435 | -116,404 | 213,867 | -229,831 |
其他收入及費用 | -84,615 | 21,087 | -21,027 | -49,828 | 2,618 | -26,523 | 15,101 | 10,055 | -32,233 | -14,343 |
利息費用 | 44,398 | 40,246 | 38,646 | 38,971 | 34,376 | 33,258 | 35,253 | 31,338 | 30,893 | 30,035 |
稅前純益 | 238,969 | -35,358 | -41,596 | -193,958 | -108,663 | -11,167 | -63,587 | -137,687 | 150,741 | -274,209 |
所得稅 | -12,115 | 30,919 | 15,883 | -110,195 | 2,907 | 5,722 | 2,348 | 183 | 2,988 | 1,815 |
稅後純益 | 251,084 | -66,277 | -57,479 | -83,763 | -111,570 | -16,889 | -65,935 | -137,870 | 147,753 | -276,024 |
基本每股稅後盈餘(元) | 1.91 | -0.51 | -0.44 | -0.66 | -0.87 | -0.13 | -0.52 | -1.10 | 1.18 | -2.21 |
稀釋每股稅後盈餘(元) | 1.90 | -0.51 | -0.44 | -0.65 | -0.87 | -0.14 | -0.52 | -1.09 | 1.19 | -2.22 |
基本平均股數(千股) | 131447.00 | 130628.00 | 129676.00 | 129143.00 | 128590.00 | 126733.00 | 126138.00 | 125613.00 | 125220.00 | 124659.00 |
稀釋平均股數(千股) | 137348.00 | 130628.00 | 129676.00 | 129143.00 | 128590.00 | 126733.00 | 126138.00 | 125613.00 | 131337.00 | 124659.00 |
還原基本每股稅後盈餘(元) | 1.91 | -0.51 | -0.44 | -0.66 | -0.87 | -0.13 | -0.52 | -1.10 | 1.18 | -2.21 |
還原稀釋每股稅後盈餘(元) | 1.90 | -0.51 | -0.44 | -0.65 | -0.87 | -0.14 | -0.52 | -1.09 | 1.19 | -2.22 |
還原基本平均股數(千股) | 131,447 | 130,628 | 129,676 | 129,143 | 128,590 | 126,733 | 126,138 | 125,613 | 125,220 | 124,659 |
還原稀釋平均股數(千股) | 137,348 | 130,628 | 129,676 | 129,143 | 128,590 | 126,733 | 126,138 | 125,613 | 131,337 | 124,659 |
EBITDA(千元) | 297,170 | 18,832 | 11,455 | -140,819 | -47,249 | 58,752 | -2,848 | -82,376 | 205,166 | -220,727 |